More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality

  • Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif. , May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality.